Nektar Therapeutics (NKTR)
1.38
-0.04
(-2.82%)
USD |
NASDAQ |
Apr 24, 16:00
1.39
+0.01
(+0.72%)
After-Hours: 20:00
Nektar Therapeutics Accounts Receivable (Quarterly): 1.205M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.205M |
September 30, 2023 | 2.204M |
June 30, 2023 | 1.335M |
March 31, 2023 | 2.995M |
December 31, 2022 | 5.981M |
September 30, 2022 | 11.53M |
June 30, 2022 | 10.01M |
March 31, 2022 | 30.22M |
December 31, 2021 | 22.49M |
September 30, 2021 | 28.99M |
June 30, 2021 | 28.87M |
March 31, 2021 | 29.16M |
December 31, 2020 | 38.89M |
September 30, 2020 | 42.92M |
June 30, 2020 | 47.24M |
March 31, 2020 | 42.03M |
December 31, 2019 | 36.80M |
September 30, 2019 | 41.20M |
June 30, 2019 | 37.30M |
March 31, 2019 | 42.89M |
December 31, 2018 | 43.21M |
September 30, 2018 | 31.94M |
June 30, 2018 | 35.32M |
March 31, 2018 | 15.61M |
December 31, 2017 | 5.014M |
Date | Value |
---|---|
September 30, 2017 | 3.314M |
June 30, 2017 | 4.114M |
March 31, 2017 | 1.565M |
December 31, 2016 | 15.68M |
September 30, 2016 | 14.25M |
June 30, 2016 | 27.78M |
March 31, 2016 | 39.68M |
December 31, 2015 | 19.95M |
September 30, 2015 | 2.966M |
June 30, 2015 | 3.68M |
March 31, 2015 | 2.885M |
December 31, 2014 | 3.607M |
September 30, 2014 | 46.07M |
June 30, 2014 | 3.047M |
March 31, 2014 | 1.855M |
December 31, 2013 | 2.229M |
September 30, 2013 | 4.557M |
June 30, 2013 | 6.041M |
March 31, 2013 | 3.647M |
December 31, 2012 | 5.805M |
September 30, 2012 | 3.911M |
June 30, 2012 | 11.36M |
March 31, 2012 | 10.80M |
December 31, 2011 | 4.938M |
September 30, 2011 | 12.91M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
1.205M
Minimum
Dec 2023
47.24M
Maximum
Jun 2020
24.28M
Average
28.99M
Median
Sep 2021
Accounts Receivable (Quarterly) Benchmarks
Stereotaxis Inc | 3.822M |
Vanda Pharmaceuticals Inc | 34.16M |
Cara Therapeutics Inc | 2.765M |
Marinus Pharmaceuticals Inc | 3.799M |
DiaMedica Therapeutics Inc | 0.071M |